Publication Listing for the MeSH term therapeutic target. Found 4 abstracts

Hammerman PS, Lawrence MS, Voet D, Jing R, Cibulskis K, Sivachenko A, Stojanov P, McKenna A, Lander ES, Gabriel S, Getz G, Sougnez C, Imielinski M, Helman E, Hernandez B, Pho NH, Meyerson M, Chu A, Chun HJ, Mungall AJ, Pleasance E, Robertson AG, Sipahimalani P, Stoll D, Balasundaram M, Birol I, Butterfield YS, Chuah E, Coope RJ, Corbett R, Dhalla N, Guin R, Hirst AC, Hirst M, Holt RA, Lee D, Li HI, Mayo M, Moore RA, Mungall K, Nip KM, Olshen A, Schein JE, Slobodan JR, Tam A, Thiessen N, Varhol R, Zeng T, Zhao Y, Jones SJ, Marra MA, Saksena G, Cherniack AD, Schumacher SE, Tabak B, Carter SL, Nguyen H, Onofrio RC, Crenshaw A, Ardlie K, Beroukhim R, Winckler W, Protopopov A, Zhang JH, Hadjipanayis A, Lee S, Xi RB, Yang LX, Ren XJ, Zhang HL, Shukla S, Chen PC, Haseley P, Lee E, Chin L, Park PJ, Kucherlapati R, Socci ND, Liang YP, Schultz N, Borsu L, Lash AE, Viale A, Sander C, Ladanyi M, Auman JT, Hoadley KA, Wilkerson MD, Shi Y, Liquori C, Meng SW, Li L, Turman YJ, Topal MD, Tan DH, Waring S, Buda E, Walsh J, Jones CD, Mieczkowski PA, Singh D, Wu J, Gulabani A, Dolina P, Bodenheimer T, Hoyle AP, Simons JV, Soloway MG, Mose LE, Jefferys SR, Balu S, O'Connor BD, Prins JF, Liu J, Chiang DY, Hayes DN, Perou CM, Cope L, Danilova L, Weisenberger DJ, Maglinte DT, Pan F, den Berg DJ, Triche T, Herman JG, Baylin SB, Laird PW, Noble M, Gehlenborg N, DiCara D, Wu CJ, Liu SY, Zou LH, Lin P, Cho J, Nazaire MD, Robinson J, Thorvaldsdottir H, Mesirov J, Sinha R, Ciriello G, Cerami E, Gross B, Jacobsen A, Gao J, Aksoy BA, Weinhold N, Ramirez R, Taylor BS, Antipin Y, Reva B, Shen RL, Mo Q, Seshan V, Paik PK, Akbani R, Zhang NX, Broom BM, Casasent T, Unruh A, Wakefield C, Cason RC, Baggerly KA, Weinstein JN, Haussler D, Benz CC, Stuart JM, Zhu JC, Szeto C, Scott GK, Yau C, Ng S, Goldstein T, Waltman P, Sokolov A, Ellrott K, Collisson EA, Zerbino D, Wilks C, Ma S, Craft B, Du Y, Cabanski C, Walter V, Wu JY, Marron JS, Liu Y, Wang K, Creighton CJ, Zhang YQ, Travis WD, Rekhtman N, Yi J, Aubry MC, Cheney R, Dacic S, Flieder D, Funkhouser W, Illei P, Myers J, Tsao MS, Penny R, Mallery D, Shelton T, Hatfield M, Morris S, Yena P, Shelton C, Sherman M, Paulauskis J, Govindan R, Azodo I, Beer D, Bose R, Byers LA, Carbone D, Chang LW, Chiang D, Chun E, Collisson E, Ding L, Heymach J, Ida C, Johnson B, Jurisica I, Kaufman J, Kosari F, Kwiatkowski D, Maher CA, Mungall A, Pao W, Peifer M, Robertson G, Rusch V, Siegfried J, Stuart J, Thomas RK, Tomaszek S, Vaske C, Weisenberger D, Wheeler D, Wigle DA, Yang P, Zhang JJ, Jensen MA, Sfeir R, Kahn AB, Chu AL, Kothiyal P, Wang Z, Snyder EE, Pontius J, Pihl TD, Ayala B, Backus M, Walton J, Baboud J, Berton DL, Nicholls MC, Srinivasan D, Raman R, Girshik S, Kigonya PA, Alonso S, Sanbhadti RN, Barletta SP, Greene JM, Pot DA, Bandarchi-Chamkhaleh B, Boyd J, Weaver J, Azodo IA, Tomaszek SC, Ida CM, Brock MV, Rogers K, Rutledge M, Brown T, Lee B, Shin J, Trusty D, Dhir R, Siegfried JM, Potapova O, Fedosenko KV, Nemirovich-Danchenko E, Zakowski M, Iacocca MV, Brown J, Rabeno B, Czerwinski C, Petrelli N, Fan Z, Todaro N, Eckman J, Rathmell WK, Thorne LB, Huang M, Boice L, Hill A, Curley E, Morrison C, Gaudioso C, Bartlett JS, Kodeeswaran S, Zanke B, Sekhon H, David K, Juhl H, Van Le X, Kohl B, Thorp R, Tien NV, Van Bang N, Sussman H, Phu BD, Hajek R, PhiHung N, Khan KZ, Muley T, Shaw KR, Sheth M, Yang L, Buetow K, Davidsen T, Demchok JA, Eley G, Ferguson M, Dillon LA, Schaefer C, Guyer MS, Ozenberger BA, Palchik JD, Peterson J, Sofia HJ, Thomson E. Comprehensive genomic characterization of squamous cell lung cancers. Nature. 2012 Sep;489(7417):519-25.   PMCID: PMC3466113

Behbakht K, Sill MW, Darcy KM, Rubin SC, Mannel RS, Waggoner S, Schilder RJ, Cai KQ, Godwin AK, Alpaugh RK. Phase II trial of the mTOR inhibitor, temsirolimus and evaluation of circulating tumor cells and tumor biomarkers in persistent and recurrent epithelial ovarian and primary peritoneal malignancies: A Gynecologic Oncology Group study. Gynecologic Oncology. 2011 Oct;123(1):19-26.   PMCID: PMC3336961 [Available on 2012/10/1]

Neuhausen SL, Brummel S, Ding YC, Singer CF, Pfeiler G, Lynch HT, Nathanson KL, Rebbeck TR, Garber JE, Couch F, Weitzel J, Narod SA, Ganz PA, Daly MB, Godwin AK, Isaacs C, Olopade OI, Tomlinson G, Rubinstein WS, Tung N, Blum JL, Gillen DL. Genetic variation in insulin-like growth factor signaling genes and breast cancer risk among BRCA1 and BRCA2 carriers. Breast Cancer Research. 2009 Jan;11(5).   PMCID: PMC2790858

Mabuchi S, Ohmichi M, Nishio Y, Hayasaka T, Kimura A, Ohta T, Kawagoe J, Takahashi K, Yada-Hashimoto N, Seino-Noda H, Sakata M, Motoyama T, Kurachi H, Testa JR, Tasaka K, Murata Y. Inhibition of inhibitor of nuclear factor-kappa B phosphorylation increase the efficacy of paclitaxel in in vitro and in vivo ovarian cancer models. Clinical Cancer Research. 2004 Nov 15;10(22):7645-54.

The above publications are sorted by year, faculty last name, and first author. Click on any highlighted author listed to find all publications attributed to that individual. Click on the publication title to see the abstract. First authors who are faculty are highlighted like this. Last authors who are faculty are highlighted like this. Other authors who are faculty are highlighted like this.

therapeutic target breast-cancer forkhead transcription factor mammographic refractory binding protein-5 igfbp-5 endothelial-cells akt single-nucleotide polymorphism carriers factor-i peripheral-blood regulated protein-kinase AKT Ovarian clinical trial adenocarcinoma resistant prostate-cancer mutations PI3K pathway inhibitor amplification progression gene pathway x-linked inhibitor circulating levels copy-number alteration fusion common variants platinum-resistant carcinoma metastatic colorectal-cancer gefitinib density Circulating tumor cells mammalian target taxol-induced apoptosis activation mTOR disease cell-survival mutation ovarian-cancer ovarian chemotherapeutic-agents multiethnic cohort carcinoma patients